Gregory Noland is the Program Director for River Blindness, Lymphatic Filariasis, Schistosomiasis, and Malaria at the Carter Center.
In 2020, Gregory Noland was named director of the Carter Center’s River Blindness Elimination Program, Lymphatic Filariasis Elimination Program, and Schistosomiasis Control Program, as well as the Center’s Hispaniola Initiative, which supports binational coordination between the Dominican Republic and Haiti to eliminate malaria and lymphatic filariasis on the island of Hispaniola.
Noland joined The Carter Center in June 2011 as a program epidemiologist with more than a decade of basic and applied research experience in parasitic diseases. Prior to joining the Center, he was a project manager and postdoctoral fellow for a University of Minnesota malaria research program in Kisumu, Kenya, in partnership with the Kenya Medical Research Institute. While in Kisumu, Noland managed operations of a more than 40-person staff on a multimillion-dollar research program to examine the epidemiology of malaria transmission and immunity in western Kenya. From 1998 to 2001, he was a guest researcher at the U.S. Centers for Disease Control and Prevention’s Division of Parasitic Diseases.
Noland received a doctorate in molecular microbiology and immunology in 2007 from Johns Hopkins University’s Bloomberg School of Public Health, where he examined the impact of intestinal helminth infection on malaria disease progression, transmission, and vaccine response. He also holds a master of public health degree in global epidemiology from the Rollins School of Public Health at Emory University and a bachelor of science degree in biology from Davidson College.